about
Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 CellsMorphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion.In vitro cytotoxicity of Nicotiana gossei leaves, used in the Australian Aboriginal smokeless tobacco known as pituri or mingkulpa.Anti-inflammatory and immunomodulatory properties of Carica papaya.Gaq proteins: molecular pharmacology and therapeutic potential.Selective anti-proliferative activities of Carica papaya leaf juice extracts against prostate cancer.Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.Activation of μ-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice.The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation.Co-Phenylcaine Spray: can we improve the taste? A randomised, double-blind, crossover study.Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway.Burn Pain: A Systematic and Critical Review of Epidemiology, Pathophysiology, and Treatment.Serum C-reactive protein levels predict regional brain responses to noxious cold stimulation of the hand in chronic whiplash associated disorders.Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon.Corrigendum to "In vitro cytotoxicity of Nicotiana gossei leaves, used in the Australian Aboriginal smokeless tobacco known as pituri or mingkulpa" [Toxicol. Lett. 254 (2016) 45-51].Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
P50
Q35982624-CBE4BDD7-C578-4470-8744-6F9B65B9A229Q38695574-9B033CA7-CCE7-4A17-8836-4A8FB6C97F01Q38771033-3BF7326A-B535-4756-B8BD-ECE6D10E5AFAQ38896690-DC2C0F9F-B09F-4F00-8133-D0946004EB36Q38999227-8C615C74-791F-4503-81CC-E44FCC94274DQ39336160-85307055-1986-4C18-8AAE-F093FC3F6589Q42513050-D7DC455B-691C-451C-8667-26103D163B8BQ44341882-5BCBBD37-B74D-4C08-8A63-981E0E775BE8Q44342364-A0C9DDFF-F3F3-4BF4-9FEB-E7725FF5A557Q47276827-7EB96051-19B0-404C-A04B-01F4848BDBE3Q47327850-0A124925-9AB7-4D09-8E57-B64380ACF4FAQ47785613-471A9B16-2A08-4838-B025-5DE170B0C61FQ47983674-3C8F8C0F-AF61-4DF2-B1D1-21830F272698Q48172747-E6661998-E803-4949-8778-30D9B9483068Q50183634-36DF45DB-ABAF-4477-BA34-875BAF20D24EQ50278934-257D1684-05CC-4ED9-B306-D8021103CB81
P50
description
bioquímic
@ca
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter J Cabot
@ast
Peter J Cabot
@ca
Peter J Cabot
@en
Peter J Cabot
@es
Peter J Cabot
@nl
Peter J Cabot
@sl
type
label
Peter J Cabot
@ast
Peter J Cabot
@ca
Peter J Cabot
@en
Peter J Cabot
@es
Peter J Cabot
@nl
Peter J Cabot
@sl
prefLabel
Peter J Cabot
@ast
Peter J Cabot
@ca
Peter J Cabot
@en
Peter J Cabot
@es
Peter J Cabot
@nl
Peter J Cabot
@sl
P1053
B-2424-2013
P106
P21
P31
P3829
P496
0000-0003-1778-3753